Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J KEATING

Showing results (731-740 of 1,115) with videos related to

Pageof 112
Sort By:
British Journal of Haematology|July 25, 2017
Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapyChristine M Stellrecht, Lisa S Chen, Mary L Ayres, et al.
Oxidative Medicine and Cellular Longevity|July 11, 2014
RCAN1 regulates mitochondrial function and increases susceptibility to oxidative stress in mammalian cellsHeshan Peiris, Daphne Dubach, Claire F Jessup, et al.
Talanta|August 9, 2018
Raman spectroscopic techniques to detect ovarian cancer biomarkers in blood plasmaMaria Paraskevaidi, Katherine M Ashton, Helen F Stringfellow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factorH M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Leukemia|June 1, 1996
Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the firstP Anderlini, H M Ghaddar, T L Smith, et al.
Blood|December 20, 2008
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradationDeepa Sampath, George A Calin, Vinay K Puduvalli, et al.
Cancer|October 5, 2002
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemiaFrancesco Onida, Greg Ball, Hagop M Kantarjian, et al.
British Journal of Haematology|March 8, 2008
Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patientsConstantine S Tam, Joselle Otero-Palacios, Lynne V Abruzzo, et al.
Cardiorenal Medicine|May 20, 2016
Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease PatientsShahanas Chathoth, Samir Al-Mueilo, Cyril Cyrus, et al.
Blood|April 16, 2008
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemiaConstantine S Tam, Susan O'Brien, William Wierda, et al.
Pageof 112

Showing results (731-740 of 1,115) with videos related to

Sort By:
Pageof 112
British Journal of Haematology|July 25, 2017
Chlorinated adenosine analogue induces AMPK and autophagy in chronic lymphocytic leukaemia cells during therapyChristine M Stellrecht, Lisa S Chen, Mary L Ayres, et al.
Oxidative Medicine and Cellular Longevity|July 11, 2014
RCAN1 regulates mitochondrial function and increases susceptibility to oxidative stress in mammalian cellsHeshan Peiris, Daphne Dubach, Claire F Jessup, et al.
Talanta|August 9, 2018
Raman spectroscopic techniques to detect ovarian cancer biomarkers in blood plasmaMaria Paraskevaidi, Katherine M Ashton, Helen F Stringfellow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1992
Treatment of chronic myelogenous leukemia in accelerated and blastic phases with daunorubicin, high-dose cytarabine, and granulocyte-macrophage colony-stimulating factorH M Kantarjian, M Talpaz, D Kontoyiannis, et al.
Leukemia|June 1, 1996
Factors predicting complete remission and subsequent disease-free survival after a second course of induction therapy in patients with acute myelogenous leukemia resistant to the firstP Anderlini, H M Ghaddar, T L Smith, et al.
Blood|December 20, 2008
Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradationDeepa Sampath, George A Calin, Vinay K Puduvalli, et al.
Cancer|October 5, 2002
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemiaFrancesco Onida, Greg Ball, Hagop M Kantarjian, et al.
British Journal of Haematology|March 8, 2008
Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patientsConstantine S Tam, Joselle Otero-Palacios, Lynne V Abruzzo, et al.
Cardiorenal Medicine|May 20, 2016
Elevated Fibroblast Growth Factor 23 Concentration: Prediction of Mortality among Chronic Kidney Disease PatientsShahanas Chathoth, Samir Al-Mueilo, Cyril Cyrus, et al.
Blood|April 16, 2008
Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemiaConstantine S Tam, Susan O'Brien, William Wierda, et al.
Pageof 112